Pluri Inc. (PLUR)
Last updated: 2026-10-24 19:18:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Pluri Inc. (PLUR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.99, with a market capitalization of $12.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.85 to $4.87. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$12.74M | |
$1.06 | |
$11.58 | |
$0.85 | |
$1.01 | |
69.97K | |
21.35K | |
-- | |
$4.87 | |
$0.85 | |
-- | |
-- |
Pluri Inc. (PLUR) Latest Closing Stock Price
Pluri Inc. (PLUR) last closed at $1.01 as of 2026-10-23 22:33:00, unchanged from the previous close of $1.01.
During the latest regular trading session, PLUR traded between $0.85 and $11.58, with a volume of 69.97K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Pluri Inc. (PLUR) 7-Day Stock Price Change
Over the past seven days, Pluri Inc. (PLUR) moved from $0.94 to $0.99, representing a gain of 5.53% ($0.05).
The stock traded between $0.85 and $1.24 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 23.35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PLUR 52-Week Price Position
Position in Range: 3.5%
PLUR is currently trading at $0.99, placing it 3.5% of the way from its 52-week low of $0.85 to its 52-week high of $4.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Pluri Inc. (PLUR)?
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Pluri Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 113 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Pluri Inc. (PLUR) Stock on MEXC
Eligible investors can buy real shares of Pluri Inc. (PLUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Pluri Inc. (PLUR) stock price today?
2.Is PLUR stock going up or down today?
3.What is PLUR pre-market price?
4.What is PLUR after-hours price?
5.Is PLUR stock trading now?
6.Where does PLUR sit relative to its 52-week high and low?
7.What sector is Pluri Inc. in?
8.What is Pluri Inc.'s market capitalization and where is it listed?
9.How is PLUR valued in terms of P/E ratio and EPS?
10.Does Pluri Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PLUR Stock Calculator
Estimate the value between PLUR shares and USD.
PLUR Shares to USD
1.00 PLUR shares = 0.992 USD
Calculations are estimates based on the latest available price and are for reference only.


